{"prompt": "['Alliance A221502', 'Hypothesis: Ten sessions of customized preoperative PR will significantly reduce the', 'number of postoperative pulmonary complications.', '2.2.2 To prospectively determine the effect of a 10-session preoperative PR on the trajectory of', 'quality of life at 3 and 6 months after the curative resection compared to a matched control', 'group.', 'Hypothesis: Ten sessions of customized preoperative PR will significantly and', 'meaningfully (more than the minimal clinically important difference) improve quality of', 'life after surgery compared to a control group.', '3.0', 'PATIENT SELECTION', 'For questions regarding eligibility criteria, see the Study Resources page. Please note that the Study', 'Chair cannot grant waivers to eligibility requirements.', '3.1', 'On-Study Guidelines', 'This clinical trial can fulfill its objectives only if patients appropriate for this trial are enrolled.', 'All relevant medical and other considerations should be taken into account when deciding', 'whether this protocol is appropriate for a particular patient. Physicians should consider the risks', 'and benefits of any therapy, and therefore only enroll patients for whom this treatment is', 'appropriate.', 'Physicians should recognize that the following may render the patient inappropriate for this', 'protocol:', 'Psychiatric illness which would prevent the patient from giving informed consent.', '3.2', 'Eligibility Criteria', \"Use the spaces provided to confirm a patient's eligibility by indicating Yes or No as appropriate.\", 'It is not required to complete or submit this page.', '3.2.1 Patient is scheduled to undergo NSCLC resection: video assisted thoracoscopy', '(VATS) or open thoracotomy for: limited resection, lobectomy, or pneumonectomy.', 'Surgery must not be scheduled to take place < 3 weeks after registration.', '3.2.2', 'Patient has a doctor diagnosis of COPD.', '3.2.3 Patient is a current or ex-smoker with a smoking history of > 10 pack years. (Calculated', 'by multiplying the number of packs of cigarettes smoked per day by the number of', 'years the person has smoked. For example, 1 pack-year is equal to smoking 20', 'cigarettes (1 pack) per day for 1 year, or 40 cigarettes per day for half a year, and so', 'on).', '3.2.4', 'Age > 18 yrs.', '4.0', 'PATIENT REGISTRATION', '4.1', 'CTEP Investigator Registration Procedures', 'Food and Drug Administration (FDA) regulations and National Cancer Institute (NCI) policy', 'require all investigators participating in any NCI-sponsored clinical trial to register and to renew', 'their registration annually.', 'Registration requires the submission of:', 'Human Subject Protection (HSP) training certificate', '9', 'NCI Version Date 7/28/2017', 'Update #3']['Alliance A221502', '4.2', 'CTEP Associate Registration Procedures/CTEP-IAM Account', 'The Cancer Therapy Evaluation Program (CTEP) Identity and Access Management (IAM)', 'application is a web-based application intended for use by both Investigators (i.e., all physicians', 'involved in the conduct of NCI-sponsored clinical trials) and Associates (i.e., all staff involved', 'in the conduct of NCI-sponsored clinical trials).', 'Associates will use the CTEP-IAM application to register (both initial registration and annual', 're-registration) with CTEP and to obtain a user account.', 'Investigators will use the CTEP-IAM application to obtain a user account only. (See CTEP', 'Investigator Registration Procedures above for information on registering with CTEP as an', 'Investigator, which must be completed before a CTEP-IAM account can be requested.)', 'An active CTEP-IAM user account will be needed to access all CTEP and CTSU (Cancer Trials', \"Support Unit) websites and applications, including the CTSU members' website.\", 'Additional', 'information', 'can', 'be', 'found', 'on', 'the', 'CTEP', 'website', 'at', 'For questions, please', 'contact', 'the', 'CTEP', 'Associate', 'Registration', 'Help', 'Desk', 'by', 'email', 'at', '.', '4.3', 'CTSU Site Registration Procedures', 'This study is supported by the NCI Cancer Trials Support Unit (CTSU).', 'IRB Approval:', 'Each investigator or group of investigators at a clinical site must obtain IRB approval for this', 'protocol and submit IRB approval and supporting documentation to the CTSU Regulatory', 'Office before they can be approved to enroll patients. Assignment of site registration status in', 'the CTSU Regulatory Support System (RSS) uses extensive data to make a determination of', 'whether a site has fulfilled all regulatory criteria including but not limited to: an active Federal', 'Wide Assurance (FWA) number, an active roster affiliation with the Lead Network or a', 'participating organization, a valid IRB approval, and compliance with all protocol specific', 'requirements.', 'Sites participating on the NCI CIRB initiative that are approved by the CIRB for this study are', 'not required to submit IRB approval documentation to the CTSU Regulatory Office. For sites', 'using the CIRB, IRB approval information is received from the CIRB and applied to the RSS in', 'an automated process. Signatory Institutions must submit a Study Specific Worksheet for Local', 'Context (SSW) to the CIRB via IRBManager to indicate their intent to open the study locally.', \"The CIRB's approval of the SSW is then communicated to the CTSU Regulatory Office. In\", 'order for the SSW approval to be processed, the Signatory Institution must inform the CTSU', 'which CIRB-approved institutions aligned with the Signatory Institution are participating in the', 'study.', '4.3.1 Downloading Site Registration Documents:', 'Site registration forms may be downloaded from the A221502 protocol page located on the', \"CTSU members' website. Permission to view and download this protocol and its supporting\", 'documents is restricted and is based on person and site roster assignment housed in the', 'CTSU RSS.', 'Go to', \"and log in to the members' area using your CTEP-IAM\", 'username and password', 'Click on the Protocols tab in the upper left of your screen', '10', 'NCI Version Date 7/28/2017', 'Update #3']\n\n###\n\n", "completion": "END"}